| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |